Benefits of Neoadjuvant Chemotherapy in NSCLC

This publication has 22 references indexed in Scilit:

• A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1994
• Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
  The Annals of Thoracic Surgery, 1993
• Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: the Toronto experience
  Lung Cancer, 1993
• Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1993
• Surgical treatment for higher stage non-small cell lung cancer
  The Annals of Thoracic Surgery, 1992
• The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.
  Journal of Clinical Oncology, 1988
• Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.
  Journal of Clinical Oncology, 1986
• A New International Staging System for Lung Cancer
  Chest, 1986
• Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lung
  Cancer, 1982
• The Significance of a Cytologically Negative Pleural Effusion in Bronchogenic Carcinoma
  Chest, 1978